4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-026535
President, R&D sold 14,811 shares at an average $24.74 ($366,367)
- President, R&D acquired 13,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-04-28 | Sale | −1,811 | $25.57 | $46,307 | 92,493 | D |
| Bergstrom Donald A President, R&D | 2022-05-02 | Option exercise | +13,000 | $4.12 | $53,560 | 105,493 | D |
| Bergstrom Donald A President, R&D | 2022-05-02 | Sale | −13,000 | $24.62 | $320,060 | 92,493 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-05-02 | Option exercise · Stock Option (Right to Buy) | −13,000 | 186,456 | D | ||
| Open-market sales · 14,811 sh · avg $24.74 · $366,367 | |||||||
Loading xslF345X03/doc4.xml…